A Promising New Avenue for Alzheimer’s Treatment: Experimental Molecule Reprograms Brain’s Immune Cells to Combat Disease

Researchers in Spain and Switzerland have identified an experimental molecule that may help restore the brain’s natural defenses against Alzheimer’s disease. The compound, known as OLE, appears to "reprogram" microglia,…

A Promising Experimental Compound Targets a Novel Pathway in Alzheimer’s Disease Progression

A groundbreaking experimental compound, developed through nearly two decades of dedicated research at ETH Zurich, is showing significant promise in offering a novel therapeutic avenue for slowing the relentless progression…

Evolutionary and social functions of gaming: Integrating experimental evidence and mathematical modeling

The emergence of gaming as a distinct human behavior has long puzzled evolutionary biologists and psychologists alike. While most mammals engage in "play"—spontaneous, goal-free activity—humans are unique in their devotion…

UK Medicines Regulator Launches Major Investigation into Clinics Making Unsubstantiated Claims for Experimental Peptide Therapies

The Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a sweeping investigation into numerous UK clinics, probing whether they are in breach of the law by promoting experimental, unregulated…